Official WeChat
  PMEC China2024

Information Center

Your current location: Pharmaceutical Network > Information Center > Interview

Chengyitong Huang Tianjun: Brain computer interface, near infrared, etc. become the company's product development direction this year

——Interview with Huang Tianjun, Deputy General Manager of Beijing Chengyitong Control Engineering Technology Co., Ltd

08:43:25, March 22, 2024 Source: Pharmaceutical Network Editor: Ah Duo Hits: 56794

download Yaoyatong APP
Subscribe to professional information at any time

share

    Share:

comment

  【 Interview with Pharmaceutical Network 】The 12th Jinan Biofermentation Expo 2024, sponsored by China Biofermentation Industry Association, was successfully concluded in Shandong International Convention and Exhibition Center on March 7. At this exhibition, Beijing Chengyitong Control Engineering Technology Co., Ltd. (hereinafter referred to as Chengyitong), as the chairman unit of China Biofermentation Industry Association, was invited to attend.
 
Huang Tianjun, the vice general manager of Chengyitong, told www.pharma.com that Chengyitong has participated in some exhibitions of the Association since its inception, so this may be the eleventh or twelfth time that the company has participated in the bio fermentation exhibition.
 
It is reported that the bio fermentation exhibition organized by China Biofermentation Industry Association is mainly divided into two parts, one is some forums, the other is the exhibition. President Huang said, "In fact, in recent years, especially in the bio fermentation exhibition, on the one hand, some forums have brought some new domestic technologies, new equipment and new products to Chengyitong, so it has brought a lot of benefits to Chengyitong; on the other hand, Chengyitong has also shown some domestic enterprises the new products launched by the company every year through these exhibitions." So in general, The benefits brought by the exhibition to Chengyitong are still very large.
 
   Three years of epidemic, steady progress is unstoppable
 
According to the data, Chengyitong was founded in 2003 and successfully listed on the GEM of Shenzhen Stock Exchange in 2015. It is an overall solution provider for intelligent manufacturing systems in domestic biological and pharmaceutical industries; R&D and manufacturing of rehabilitation equipment, professional technical services for rehabilitation and elderly care, medical equipment providers; Environmental disinfection/sterilization overall solution provider.
 
Mr. Huang said that since its successful listing in 2015, Chengyitong has completely opened the link of the biomedical automation industry chain through mergers and acquisitions, capacity expansion and other means, so the company's development has also made a leap.
 
"Especially in 2017, we acquired Guangzhou Longzhijie and established a big health sector, focusing on rehabilitation medicine and elderly care medicine, which also enabled Chengyitong to develop in the big health industry. Long Zhijie is an innovative and leading rehabilitation medical equipment enterprise. Its products have entered more than 5000 medical institutions in China, which has also provided great help for the development of Chengyitong's overall size. It can be said that the development of Honesty and Benevolence in the past two years has gone through three years of epidemic, but it is also in a steady and progressive stage of development. " Mr. Huang said.
 

 
 
   "Double sector business" goes hand in hand to help the company's new development
 
At present, the two major sectors of Chengyitong include the pharmaceutical biological intelligence manufacturing sector and the rehabilitation medical equipment sector, which are going hand in hand to help the company develop more steadily and sustainably in the future.
 
Among them, in terms of intelligent manufacturing, President Huang introduced the intelligent manufacturing of biology, which is similar to the part displayed in this exhibition of Chengyitong. "In fact, a vision of our company is to improve the automation level of domestic biomedical industries. Through the development of more than 20 years, we can also see that our modern enterprise automation level is gradually improving. Through automation, our process level is also very stable, including the traceability of our data and the consistency of drug quality In fact, this is all due to the application of automated and intelligent equipment to our actual production, so in the area of intelligent manufacturing, our future development direction is also to improve everyone's intelligent manufacturing level, including the application of some AI now, the combination of some big data, etc. Chengyitong has also been recognized by the Ministry of Industry and Information Technology of the People's Republic of China, It was recognized as a qualified supplier of the overall solution of national intelligent manufacturing, so it also gave a high evaluation to Chengyitong. " In addition, the company's intelligent manufacturing sector, as well as plant extraction business, "Plant extraction is also in response to the development of the country in the field of traditional Chinese medicine. We have also acquired a related enterprise to promote plant extraction. At the same time, we have now set up a research institute for the level of plant extraction. Through the research institute, we have introduced some university talents, such as we have set up a professor workstation with China Agricultural University to carry out the research by introducing high capital resources from universities The research and development of some plant extracts has now reached a very good level. "

 
In the rehabilitation and medical sector, President Huang said that the focus should be on solving public health problems, "Because the aging problem in China is also gradually emerging, some of our domestic medical resources are still relatively concentrated in some large and medium-sized cities or some central cities, but our vast majority of people may need some basic rehabilitation medicine. If they are concentrated in large cities, our medical resources will be squeezed, so the focus of our mission in this area is still the following Sink, sink our rehabilitation business to township hospitals and rural hospitals, and establish our grass-roots rehabilitation business, so that people can get a good rehabilitation process without going into big hospitals or big cities. "
 

 

 
   Focus on talent echelon construction and retain more young people
 
Talent core competence is the key factor of enterprise core competitiveness. In order to improve the core competitiveness of enterprises, Chengyitong has always attached great importance to the construction of talent echelon.
 
"We have made full use of the preferential policies given by Beijing to introduce a lot of high-end talents, because everyone knows that it is difficult to obtain a Beijing hukou now. We have made full use of the relevant policies to solve the problem of the hukou of core employees, so that they can stay in the enterprise and work more confidently for the enterprise. We have also retained a lot of outstanding talents through some policies given by the state, including the household registration policy, the selection policy of Beijing outstanding youth, etc. " Mr. Huang said.
 
At the same time, in order to meet the needs of employee development and talent incubation, Chengyitong also provides employees with diversified promotion channels. For example, for technical talents, we can take the route of technology promotion, and for management talents, Chengyitong can provide access for managers to promote. In addition, Chengyitong also integrates humanistic care into the enterprise to stimulate employees' vitality. For example, on the employee's birthday, March 8th, Youth Day, Father's Day and other festivals, Chengyitong will send gifts and shopping cards to employees or their families.
 
General Manager Huang said, "Generally speaking, the company hopes to retain more young people and have more excellent young people to better serve the enterprise. The company has a promising future. In addition to solving the household registration problem of outstanding talents, the company is also gradually solving their housing problems and solving their accommodation needs through some low-cost housing, public rental housing, etc."
 
   Brain computer interface, near infrared, etc. become the company's research and development direction
 
Brain computer interface is an important part of China's "Brain Project". In recent years, with the continuous development of brain computer interface technology and the continuous development of domestic and foreign scientific research teams, brain computer interface has made a lot of progress. In the future, brain computer interface technology is expected to be widely used in medical, rehabilitation, entertainment and other fields, which has attracted many enterprises to layout.
 
Chengyitong also regards brain computer interface as the future direction of product research and development. President Huang said that Chengyitong is making in-depth communication and discussion with well-known universities in Beijing, "Because now intelligent AI and brain computer interface are developing very rapidly, which is also the key development direction supported by the state. In addition, the application prospect is very broad, especially brain computer interface technology. Its most widely used and successful medical and rehabilitation industry can effectively connect with the company's rehabilitation equipment business, especially in the field of neural rehabilitation, such as stroke patients The motor function of the limbs of paralytic patients is damaged. The traditional physical therapy for rehabilitation is usually passive and repetitive rehabilitation through muscle movement. The brain computer interface can cooperate with different rehabilitation equipment to carry out active rehabilitation of multiple limbs and multiple postures, driven by the subjective intention of the patients, to promote the reconstruction of the mental channel and greatly improve the rehabilitation efficiency. "
 
At the same time, Chengyitong is also doing research and development in the near infrared area robot To take samples instead of on-site labor. Another is our development in the direction of AGV, because many workshops are working overtime and many people in charge are pulling a car. Now we want to develop an AGV, an unmanned factory, which mainly replaces on-site labor. In fact, the focus of research and development of these products is to help our enterprise reduce costs and improve efficiency. "
 
In addition to products, Chengyitong has also carried out research and development in technology. "We are now cooperating with domestic universities, such as Tsinghua University, Agricultural University, Tianjin University, Jiangnan University, and other universities in some key laboratories and key departments in the biomedical industry to optimize and screen some varieties to further help enterprises." President Huang pointed out that, Because most of the current varieties may be imported from abroad and need to be screened by themselves, Chengyitong can help enterprises to skip this step and start from the research and development of varieties to help people better improve the time and efficiency of transformation.
 
   We should not only listen to domestic voices, but also hope to hear foreign voices
 
Jinan Exhibition is the first biological fermentation exhibition this year. As for the experience brought by this exhibition, Mr. Huang said frankly, "The effect of the exhibition is still great, including the benefits of our various We Media networks. We hope to show more customers and the society the better strength of Honesty, Benefitment and Communication through this way, and also receive more customers through the exhibition, a good media, to learn about the situation, because we may be implementing our plans this year. Many customers come here to exchange the actual situation of the project. They still hope that we can have better communication with them after the exhibition, so that the project can be better implemented. So I think the exhibition is very successful. Chengyitong will participate in many exhibitions in a year. In fact, it is more about telling our peers, telling our peers, and telling our customers, What new things are coming out of Chengyitong, and what new processes are there to help people solve some practical problems? "
 
The next Shanghai Fermentation Exhibition will be held in August 24. In this regard, President Huang affirmed the new changes of the exhibition in recent years, and looked forward to the future exhibition, "In fact, I think the fermentation exhibition in the past two years has changed a lot. One of the big changes is that in the past, it may have been just a meeting. Now, it has introduced more new products, new research and development, new processes in China, combined with many colleges and universities. I also attended the first day of the exhibition, including academicians and other experts on the development prospects of the industry A prospect is made. In fact, there has been such a remarkable change in this area in the past two years, but I hope that some foreign forums can also be introduced into the future exhibitions. We want to know which colleges and universities in China are doing some work, or some units in the country are doing some work, but I also want to hear what some foreign counterparts are doing? What is the degree of this process abroad? Let's see what others are doing and how they can help us improve. We still hope to strengthen this part through the strength of the Association, so that we can hear more foreign voices. "
 

 

 

 
Disclaimer: In any case, the information or opinions expressed in this document do not constitute investment advice to anyone.
  • Copyright and Disclaimer: All works marked "Source: Pharmaceutical Network" on this website are copyrighted or used by Zhejiang Xingwang Baomingtong Network Co., Ltd. Pharmaceutical Network. Without the authorization of this website, these works cannot be reprinted, extracted or used in other ways. If the work has been authorized to use by this website, it should be used within the scope of authorization, and the "Source: www.pharma.com https://www.zyzhan.com ”。 Anyone who violates the above statement will be investigated for relevant legal responsibility.
  • This website reprints and indicates the works from other sources (other than www.pharma.com) in order to convey more information, which does not mean that this website agrees with its views or is responsible for its authenticity, and does not bear the direct liability and joint liability for the infringement of such works. When other media, websites or individuals reprint works from this website, they must retain the first source of works indicated on this website, and bear legal responsibilities such as copyright. If it involves the content, copyright and other issues of the work, please contact this website within one week from the date of publication of the work, otherwise it will be deemed as a waiver of relevant rights.

I want to comment

Civilized Internet access, rational speech. (You can also enter 200 characters)

All comments only represent the opinions of netizens, and have nothing to do with the position of this site.

QQ

consulting center

Advertising consultation QQ:652787579

Exhibition cooperation QQ:357275273

Official WeChat Publish RFQ Suggestion feedback Back to Home
Back to top